Martini Jeffrey S
Chief Scientific Officer
Officer
Latest Insider Transactions
Showing 10 of 20 transactions (past 365 days)
| 2026-11-12 | 2026-11-11 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 1,467 | $165.78 | $243,196 |
| 2026-11-12 | 2026-11-11 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 1,200 | $167.75 | $201,299 |
| 2026-11-12 | 2026-11-10 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 550 | $169.03 | $92,964 |
| 2026-11-12 | 2026-11-10 | PVLA Palvella Therapeutics, Inc. | CSO | Exercise Conversion | 4,266 | $7.53 | $32,123 |
| 2026-11-12 | 2026-11-11 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 600 | $168.73 | $101,240 |
| 2026-11-12 | 2026-11-11 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 1,650 | $164.14 | $270,834 |
| 2026-11-12 | 2026-11-10 | PVLA Palvella Therapeutics, Inc. | CSO | Exercise Conversion | 1,984 | $9.79 | $19,423 |
| 2026-11-12 | 2026-11-10 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 100 | $163.34 | $16,334 |
| 2026-11-12 | 2026-11-10 | PVLA Palvella Therapeutics, Inc. | CSO | Exercise Conversion | 1,984 | $9.79 | $19,423 |
| 2026-11-12 | 2026-11-11 | PVLA Palvella Therapeutics, Inc. | CSO | Sale | 1,133 | $166.76 | $188,942 |
PVLA
CSO
Exercise Conversion
$32.1K
4,266 shares @ $7.53
Filed 2026-11-12Trade 2026-11-10
Palvella Therapeutics, Inc.PVLA
CSO
Exercise Conversion
$19.4K
1,984 shares @ $9.79
Filed 2026-11-12Trade 2026-11-10
Palvella Therapeutics, Inc.PVLA
CSO
Exercise Conversion
$19.4K
1,984 shares @ $9.79
Filed 2026-11-12Trade 2026-11-10
Palvella Therapeutics, Inc.Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.